Direct Nitric Oxide Generation

The source claims the lozenge technology normalizes high blood pressure without lowering normal or low blood pressure further. The product-specific claims are not independently evaluated in the transcript and lack full clinical trial details. The lozenge formulation is described as a mouth-dissolving matrix that produces nitric oxide gas. The topical serum is described as a dual-chamber formulation that generates nitric oxide on the skin and produces visible vasodilation and capillary recruitment. Direct nitric oxide generation is proposed as an alternative to precursor strategies that depend on impaired biological pathways.